HK40021665A - Nutritional dietary composition and edible product - Google Patents

Description

Nutritional dietary compositions and edible products

Technical Field

The invention relates to the field of food, in particular to a nutritional dietary composition and an edible product containing the same.

Background

More and more studies indicate that pathogenesis should be traced for type II diabetics. At present, in the national resident dietary guidelines and diabetic nutrition guidelines, the carbohydrate intake ratio of normal people and diabetic patients is recommended to be about 60%, and the recommended carbohydrate intake amounts of the normal people and the diabetic patients are basically consistent. However, studies have shown that in cases where the total amount of ingested carbohydrate exceeds the body's ability to metabolize the carbohydrate for the sugar, high insulin secretion is induced, and insulin resistance is caused by the stimulation of insulin secretion. Therefore, the above guidelines for diabetics are not reasonable. Meanwhile, the excessive intake of energy substances comprises the imbalance of total intake energy and the proportion of nutrient elements, however, the current intake of nutrient diet of Chinese is only about 10 g, which is far lower than the intake of nutrient diet of 35g per day recommended by WHO for adults. Thus, the current nutritional intake is very disadvantageous for diabetics, who however do not receive suitable dietary guidelines and do not have a palatable food available on the market that can replace the daily diet specifically for diabetics.

Westernized meals bring in excess energy intake, and chinese populations are faced with excessive energy intake and a severe excess of high-glycemic index food and drink intake. The combined action of the two factors results in the current Chinese huge number of people with type 1.14 million diabetes mellitus and more huge number of people with sugar intolerance (5.1 million), and 93 percent of people with sugar intolerance are likely to be changed into patients with type 2 diabetes mellitus if the people do not eat compound food.

Therefore, the main problem faced by the current diabetics is that most of the products aiming at the diabetics on the market contain medicinal components and have poor mouthfeel, and the formula foods aiming at the diabetics without the medicinal components do not form a systematic research system and do not realize the research of people, so that the theory and the effect of the products cannot be demonstrated and verified. Therefore, a palatable, non-medicated, daily-based product that can substantially ameliorate diabetes is highly desirable to diabetics.

The Daqing study in 2019 promoted the global exercise of dietary intervention in diabetes reversal in the New England journal of medicine, and the study of a large sample queue in 30 years showed that dietary intervention plays an important role in diabetes prevention intervention and reversal. The medical expenses of China on diabetes are 11071 million RMB at present, the nation and patients are overwhelmed, and the nation, scientists and patients urgently need new foods conforming to the theoretical system.

Disclosure of Invention

The invention aims to overcome the problems in the prior art and provide a nutritional dietary composition which can effectively regulate blood sugar, has good mouthfeel and no side effect and can be eaten instead of meals, and an edible product containing the nutritional dietary composition.

The nutritional dietary composition and the edible product can fundamentally improve the physical function of the diabetic patients through a food therapy mode, not only can gently and stably reduce blood sugar and repair the pancreatic island function, but also can effectively improve the comprehensive physical quality. The nutritional dietary composition and the edible product have good mouthfeel, and can improve the eating desire of eaters, thereby ensuring the realization of the food therapy effect.

The inventor of the invention finds that certain specific food materials are combined in a specific proportion, so that comprehensive influence can be generated on the body, the food materials which do not have the obvious blood sugar improving effect can be mixed in a specific proportion, the blood sugar regulating effect can be improved, and the effect of improving and even treating diabetes can be fundamentally achieved.

In order to achieve the above object, the present invention provides in a first aspect a nutritional dietary composition comprising flax seeds, chia seeds, a fraction a and a fraction B, wherein the fraction a is soybeans and/or red beans and the fraction B is a mixture of total dietary fibers and total proteins in a weight ratio of 0.8-1: 1. a plant seed or a mixture of plant seeds having a total protein content of 8-25 wt% and a total carbon water content of 20-75 wt%;

wherein, relative to 100 weight parts of the flaxseed, the content of the chia seed is 40-70 weight parts, the content of the A component is 40-65 weight parts, and the content of the B component is 20-45 weight parts.

According to a most preferred embodiment of the present invention, the component A is soy.

In order to make the B component generate synergistic effect with other components better, preferably, the content weight ratio of the total dietary fiber to the total protein of the B component is 0.85-0.98: 1. a plant seed or a mixture of plant seeds having a total protein content of 12-20 wt% and a total carbon water content of 45-75 wt%.

Further preferably, wherein the content weight ratio of the total dietary fiber to the total protein of the B component is 0.85-0.98: 1. a plant seed or a mixture of plant seeds having a total protein content of 16-20 wt% and a total carbon water content of 50-65 wt%.

The component B can be any substance satisfying the above conditions, and according to a specific embodiment of the present invention, the component B is selected from one or more of pumpkin seeds, black beans, chickpeas and whole wheat; preferably one or more selected from pumpkin seeds, chickpeas and whole wheat; more preferably pumpkin seeds and/or chickpeas.

In the present invention, the terms "total dietary fiber", "total protein", "total carbohydrate" have the meaning conventional in the art, and the contents thereof are measured according to the methods prescribed in GB 5009.88-2014, GB 5009.5-2016 and GB10769-2010, respectively.

In order to further improve the synergistic effect between the components and thus better achieve the object of the present invention, preferably, the chia seed is contained in an amount of 42 to 60 parts by weight, the a component is contained in an amount of 42 to 60 parts by weight, and the B component is contained in an amount of 22 to 40 parts by weight, relative to 100 parts by weight of the flaxseed.

In order to further improve the synergistic effect between the components and thus better achieve the object of the present invention, it is further preferred that the chia seed is present in an amount of 45 to 55 parts by weight, the a component is present in an amount of 45 to 55 parts by weight, and the B component is present in an amount of 25 to 35 parts by weight, relative to 100 parts by weight of the flaxseed.

In the present invention, the combination form of each component in the nutritional dietary composition is not particularly limited, and for the convenience of production, transportation and sale, the combination form in which each component is separately packaged, the combination form in which each component is premixed, and other combination forms can be selected according to specific situations, and all fall within the protection scope of the present invention.

In the present invention, the physical form of each component in the nutritional dietary composition is not particularly limited, and may be selected from raw natural form, powder form, capsule form (packaged in a capsule), solid-liquid mixed form (obtained by adding liquid such as beverage, paste or porridge), pellet form, etc. according to specific conditions, and all fall within the scope of the present invention.

Preferably, the nutritional dietary composition is in powder form. More preferably, the particle size of the powdered powder is 100-140 mesh.

Preferably, the flaxseed is flaxseed meal, which may be obtained by grinding flaxseed and drying to a powder.

Preferably, the chia seed is chia seed meal, which may be obtained by grinding chia seed and drying to powder.

Preferably, the component A is powder of component A, which can be obtained by grinding and drying to powder, or by pre-treating and grinding and drying to powder, for example, soybean is roasted, peeled, ground and dried to powder to obtain soybean powder.

Preferably, the component B is powder of the component B, and the powder of the component B can be obtained by grinding and drying into powder, or can be obtained by pre-treating, grinding and drying into powder.

In the present invention, the term "flaxseed" has the meaning conventional in the art, specifically, flaxseed (L Umitationssinum) is called flax seed, flax, etc., and has a mild nature and a sweet taste.

Specifically, Chia (Chia Seed), also known as Chia Seed, academia gordon euryale (Salvia Hispica L.), mint plants, Chia Seed is rich in the human essential fatty acid α -linolenic acid (A L A; 18:3(n-3)), and various antioxidant active ingredients (chlorogenic acid, caffeic acid, myricetin, quercetin, kaempferol, etc.), are sources of natural omega-3 fatty acids, and contain abundant dietary fibers, proteins, vitamins, minerals, etc.

In the present invention, the term "soybean" has a meaning conventional in the art, and is generally considered to have the following effects: 1. the soybean protein and the stigmasterol in the soybeans can obviously improve and reduce the blood fat and the cholesterol, thereby reducing the probability of suffering from cardiovascular diseases; 2. the soybean fat is rich in unsaturated fatty acid and soybean phospholipid, and has effects of maintaining blood vessel elasticity, nourishing brain and preventing fatty liver formation; 3. semen glycines is rich in saponin, protease inhibitor, isoflavone, molybdenum, selenium, etc., and has effect in inhibiting prostatic cancer, skin cancer, intestinal cancer, esophageal cancer, etc.; 4. the phytoestrogen in the soybeans is very similar to the estrogen generated in a human body in structure, can be the best food for the adjuvant treatment of the climacteric syndrome of women, is economical and effective, and has no side effect; 5. the soybean is also rich in calcium, and has therapeutic effect on climacteric osteoporosis; 6. the soybean is beneficial to dry and rough skin and dry hair, can improve the metabolism of the skin, promote the organism to expel toxin and keep the skin young; 7. the saponin substances in semen glycines can reduce fat absorption function and promote fat metabolism; 8. the soy fiber also accelerates the passage of food through the intestine.

In the present invention, the term "red bean" has a meaning conventional in the art. Generally, the red beans have the following functions: invigorating spleen and nourishing spleen, nourishing stomach and invigorating stomach, replenishing blood and nourishing blood, coordinating intestines and stomach, clearing lung-heat and moistening lung, relieving summer heat, expelling toxin and detoxicating, etc.

In the present invention, the term "pumpkin seeds" has a meaning conventional in the art. Specifically, pumpkin seeds contain amino acids, fatty oils, proteins, vitamin B1, vitamin C, vitamin E, linolenic acid, phytosterols, etc., which are beneficial to human health.

In the present invention, the term "black soybean" has a meaning conventional in the art. In particular, the black beans are rich in vitamins, yolk, melanin, lecithin and other substances, wherein the contents of B vitamins and vitamin E are high, and the black beans have the effects of nutrition and health care. Generally, black beans are considered to have the following effects: 1. reducing the blood cholesterol level of the human body and reducing the risk of heart disease; 2. free radical is eliminated, and aging is delayed; 3. regulating blood lipid protein, and preventing and treating blood lipid increase; 4. an immune modulating function; 5. can be used for treating anemia.

In the present invention, the term "chickpeas" has the meaning conventional in the art. The chickpea has rich nutrient components and good taste. It is generally believed that chickpeas have the following effects: has effects in invigorating spleen, replenishing qi, warming kidney, supporting yang, moistening lung, relieving cough, and lowering blood cholesterol level, and can be used for treating bronchitis, mucositis, cholera, constipation, dysentery, dyspepsia, flatulence, venomous snake bite, and sunstroke.

In the present invention, the term "whole wheat" has the meaning conventional in the art, i.e. wheat grains comprising outer gluten. In particular, whole wheat is rich in starch, protein, fat, minerals, calcium, iron, thiamine, riboflavin, niacin, vitamin A, and the like, and also contains allantoin, and wheat germ is also rich in dietary fiber and vitamin E, as well as small amounts of arginine, amylase, sitosterol, lecithin, and proteolytic enzyme.

Other unexplained terms in the present invention have the same meaning as those conventionally used in the art.

The main components in the nutritional dietary composition do not have special effects on the blood sugar regulation function of the human body, but the inventor of the invention finds that the main components can respectively generate the original beneficial effects on the human body and can generate the synergistic effect on the function of the human body by mixing the main components in a specific proportion, so that the nutritional dietary composition can specifically generate the beneficial effects on the blood sugar regulation function of the human body, and particularly has obvious effect on diabetic patients.

Moreover, it can be seen that all the ingredients in the nutritional dietary composition of the present invention have no obvious unpleasant taste (bitter, astringent, etc.), even most of the ingredients are edible materials which people enjoy, which ensures the palatability of the product, which is an important index for the products which need to be eaten by people for a long time.

The nutritional dietary compositions of the present invention may also contain other components conventional in the art, provided that they do not antagonize one or more of flaxseed, chia seed, a component and B component, and are within the scope of the present invention.

The nutritional dietary compositions of the present invention may be obtained by processes conventional in the art, such as screening, crushing, mixing, drying, sterilizing, inner packaging, outer packaging, finishing, warehousing, etc., and will not be described herein in detail.

The nutritional dietary composition of the invention can be directly eaten without being matched with other components, and can achieve good effect. The eating mode of the nutritional dietary composition of the present invention is not particularly limited, for example, when the nutritional dietary composition is in a powder form, the nutritional dietary composition can be directly brewed with water to be pasty for drinking, or added into porridge for eating, etc.; when the raw material particles are mixed, the mixture can be cooked into porridge for eating, and the like.

According to a specific embodiment of the invention, the nutritional dietary composition is a food for regulating blood sugar, which is mainly suitable for people with abnormal blood sugar indexes such as type II diabetes and the like, and is especially suitable for patients who have poor health and have other adverse effects on the patients due to rapid blood sugar reduction, and in such a case, the daily consumption is preferably 60-120g, so that the effects that: the reduction ratio of the glycated hemoglobin can be 1.2% or more in 84 days, and can be 1.6% or more in a preferred embodiment; the aim that the glycosylated hemoglobin is less than 7 percent can be basically achieved within 84 days, and the achievement proportion is more than 95 percent and even can reach 100 percent; the fasting blood sugar value can be reduced by more than 35% or even can reach more than 40% within 84 days; and can effectively improve the intestinal function and produce comprehensive regulation effect on the organism.

According to another embodiment of the invention, the nutritional dietary composition of the invention is a food product for weight loss, in which case the daily consumption is preferably in the range of 30-80g, so as to reduce the adverse effects on the body during diet and/or exercise and to contribute to the weight loss effect.

According to another embodiment of the invention, the nutritional dietary composition is a food for improving the body constitution, which is suitable for healthy people, preferably, the daily consumption is 10-50g, and can supplement balanced nutrition for the body, regulate the body constitution and enhance the body immunity.

In a second aspect, the present invention provides an edible product comprising the nutritional dietary composition according to the first aspect of the invention.

The edible product of the present invention may be in various forms that are conventional in the art and are within the scope of the present invention so long as the nutritional dietary composition of the present invention is contained therein.

In the present invention, the edible product may also contain ingredients that conventional edible products may contain, such as sweeteners, dietary fibers, nuts, and the like.

The content of the nutritional dietary composition in the edible product may be any content, but in order to ensure a certain effect, the content of the nutritional dietary composition is preferably not less than 40% by weight, based on the total weight of the edible product.

According to a specific embodiment of the invention, the edible product is a food for regulating blood sugar, for example, as a meal replacement product, a staple food product or a health care product for reducing glycated blood cell protein and promoting insulin secretion of islet B cells, and the like, and the edible product is mainly suitable for people with abnormal blood sugar indexes such as type ii diabetes, especially for patients who are not good enough in body and have other adverse effects on the patients due to rapid blood sugar reduction, and in such a case, the daily consumption of the edible product in terms of the nutritional dietary composition is preferably 60-120g, so that a good weight-reducing effect can be achieved while no obvious harm to the body is ensured.

According to another embodiment of the invention, the edible product of the invention is a food product for weight loss, e.g. as a meal replacement product, a staple food product or a weight loss product for weight loss, in which case the daily consumption is preferably in the range of 30-80g based on the nutritional dietary composition therein, so as to be able to alleviate the body's adverse effects on diet and/or exercise and to contribute to the weight loss effect.

According to another embodiment of the invention, the edible product is a food for improving body constitution, for example, as a meal replacement product, a staple food product or a health care product for supplementing nutrients, which is suitable for healthy people, and preferably, the edible amount per day is 10-50g based on the nutritional dietary composition, so that the edible product can supplement balanced nutrition for the body, regulate body constitution and enhance body immunity.

Through the technical scheme, compared with the prior art, the invention at least has the following advantages:

(1) the nutritional dietary compositions and edible products of the present invention are effective in ameliorating or even treating type two diabetes;

(2) the nutritional dietary composition and the edible product have mild performance and no side effect, can enable the blood sugar reduction rate of an eater to be more gradual, and are particularly suitable for patients who have poor health and have other adverse effects on the patients due to rapid blood sugar reduction;

(3) the nutritional dietary composition and the edible product of the invention have rich nutrition and have beneficial effect on the comprehensive physical quality of eaters;

(4) the nutritional dietary composition and the edible product of the invention can also be suitable for healthy people to eat, and can play a role in helping to lose weight;

(5) the nutritional dietary composition and the edible product have good mouthfeel and fragrant taste, and reduce the rejection of eaters, thereby being beneficial to the eaters to insist on eating and further achieving the curative effect;

(6) the nutritional dietary composition and the edible product of the invention have simple preparation process and can be suitable for industrial large-scale production.

The endpoints of the ranges and any values disclosed herein are not limited to the precise range or value, and such ranges or values should be understood to encompass values close to those ranges or values. For ranges of values, between the endpoints of each of the ranges and the individual points, and between the individual points may be combined with each other to give one or more new ranges of values, and these ranges of values should be considered as specifically disclosed herein.

Detailed Description

The present invention will be described in detail below by way of examples. The described embodiments of the invention are only some, but not all embodiments of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.

The following examples serve to illustrate the nutritional dietary compositions of the invention, while the edible products of the invention may be obtained in any manner, as long as the nutritional dietary compositions meet the daily intake criteria, i.e. comparable results are achieved, and thus validation of the effects of the nutritional dietary compositions is comparable to that of the edible products. For the sake of brevity, no further description of the edible product of the present invention is provided in the following detailed description.

In the following examples, the B components referred to have the parameters indicated in Table 1. Wherein, the contents of the total dietary fiber, the total protein and the total carbon water are respectively measured according to the methods specified in GB 5009.88-2014, GB 5009.5-2016 and GB 10769-2010.

TABLE 1

Nutritional parameters (g/100g)	Pumpkin seed	Black soya bean	Chickpea	Whole wheat
					Total protein	19	8.9	19	13
Total carbohydrate	54	24	61	72
					Total dietary fiber	18	8.7	17	11
Total dietary fiber/Total protein	0.95	0.98	0.89	0.85

Examples 1 to 7

In the following examples and comparative examples, the preparation was carried out in the following manner:

(1) preparing the raw materials shown in Table 2, respectively crushing and drying, and screening powder with the particle size range of 100-140 meshes;

(2) the nutritional dietary compositions of the examples were obtained by weighing the powders of the respective components in the weight ratios shown in table 2 and mixing them uniformly, and the obtained nutritional dietary compositions were recorded as S1-S7, respectively.

TABLE 2

	Linseed	Chia seed	Component A	B component
					Example 1	100	51	Soya bean, 52	Pumpkin seeds, 33
Example 2	100	45	Soya bean, 55	Pumpkin seeds, 35
					Example 3	100	55	Yellow bean, 45	Pumpkin seeds, 25
Example 4	100	57	Soybeans, 42	Chickpeas, 22
					Example 5	100	42	Soya bean, 60	Whole wheat, 38
Example 6	100	40	Soya bean, 40	Black soya bean, 20
					Example 7	100	51	Red bean, 52	Pumpkin seeds, 33
Comparative example 1	151	0	Soya bean, 52	Pumpkin seeds, 33

Comparative example 1

The procedure is as in example 1, except that chia seed meal is not added, but is replaced by linseed meal of the same quality, as shown in table 2.

The resulting nutritional dietary composition was scored as D1.

Comparative example 2

An edible product with hypoglycemic effect is purchased commercially, and the ingredients of the product mainly comprise: soy protein isolate, oatmeal, skim milk powder, resistant dextrin, isomaltooligosaccharide, concentrated milk protein powder, polydextrose, instant soybean powder and collagen.

The product parameters of the product mainly comprise: the total calories per 100g product was 1416KJ, total protein 35g, net carbohydrate 28.2g, total fat 3.8g, total dietary fiber 25g, and total carbohydrate 53.2 g.

This commercial product was designated as D2.

Test example

The test examples were used to test the effect of the nutritional dietary compositions obtained in the examples on diabetic patients. Wherein, the volunteers of the diabetic patients participating in the test need to meet the following conditions:

a. signing an informed consent;

b. diagnosing type 2 diabetes with a course of less than or equal to 5 years;

c. males and females between 18-70 years of age inclusive;

d. during screening, the HbA1c level is more than or equal to 7.5% and less than or equal to 9%;

e. the Body Mass Index (BMI) is more than or equal to 23kg/m2 and less than or equal to 34kg/m 2;

f.3 stable to receive blood sugar lowering therapy without SG L T-2i and G L P-1 a;

g. blood Cr is less than or equal to 1.5mg/d L, and A L T is less than or equal to 2 times of the upper normal limit;

h. non-pregnant or lactating patients, non-pregnant preparers;

i. blood glucose monitoring can be performed and is willing.

The test method comprises the following steps:

(1) 28 volunteers were set as a control group and 28 volunteers were set as an experimental group for each of the nutritional dietary compositions S1-S7 and D1-D2 (further divided into an example group for tests S1-S7 and a comparative example group for tests D1-D2);

(2) the test period was 84 days during which all volunteers underwent dietary intervention;

(3) volunteers in the example group S1-S7 and the comparative example group D1 were given 100g of the nutritional dietary composition (eaten directly as a paste by direct water-infusion) per day, divided into three meals;

the control volunteers provided 100g of regular steamed bread per day and controlled the carbohydrate content to about 60% (i.e., as recommended by national resident dietary guidelines and diabetic nutritional guidelines);

d2 comparative group takes 100g D2 products every day, and takes the products after being mixed with water into paste, and three meals are equally divided;

(4) ensure no difference in daily intake of nutrients such as protein, fat and vegetables between the experimental group and the control group.

During the test, the following parameters were monitored:

(1) survey of degree of satisfaction of taste

Please each volunteer to score the satisfaction degree of the mouth feel of the product eaten by the volunteer according to subjective feeling, wherein the score is 10, and the higher the score is, the higher the satisfaction degree is. The scores for each product were averaged and are reported in table 3.

TABLE 3

	Satisfaction degree of taste (score 10)
		Control group	9.2
Example 1	7.6
		Example 2	7.5
Example 3	7.3
		Example 4	7.2
Example 5	7.0
		Example 6	6.7
Example 7	7.5
		Comparative example 1	6.5
Comparative example 2	6

As can be seen from table 3, the volunteer satisfaction with the mouthfeel of the product of the invention can reach at least 6.7 points and in a preferred embodiment even 7.6 points, which gives the consumer the hope of being able to persist for a long time to ensure that the product of the invention can ultimately achieve the desired effect. It is also understood that even though comparative example 2 or other prior art products are theoretically more effective, it is meaningless to talk about the effect if the mouthfeel is not acceptable to the consumer.

(2) Glycated hemoglobin HbA1c (%):

glycated hemoglobin HbA1c was measured by volunteers at day 0, day 28, day 56 and day 84 participating in the test in the trio hospital, respectively, and the decrease ratios of day 28, day 56 and day 84 with respect to day 0 were calculated (decrease ratio ═ b (HbA 1c value on day 0-HbA 1c value on day N) ÷ HbA1c value on day 0 × 100%), respectively, and the average values of the experimental group and the control group were calculated, respectively, with the results shown in table 4.

TABLE 4

Reduction ratio (%)	Day 28	Day 56	Day 84
				Control group	0.55	0.95	1.15
Example 1	0.95	1.45	1.75
				Example 2	0.87	1.41	1.65
Example 3	0.85	1.38	1.6
				Example 4	0.82	1.32	1.58
Example 5	0.78	1.3	1.45
				Example 6	0.76	1.26	1.38
Example 7	0.7	1.23	1.25
				Comparative example 1	0.65	0.9	1.1
Comparative example 2	0.67	1.05	1.15

As can be seen from Table 4, the example group adopting the technical scheme of the invention can effectively reduce the glycosylated hemoglobin of the patient, and the effect is obviously better than that of the control group and is obviously better than that of the comparative example group.

(3) Target achievement ratio of glycosylated hemoglobin less than 7%

The number of persons who reached the target of less than 7% of glycated hemoglobin in the experimental group and the control group on days 0, 28, 56 and 84, respectively, was recorded, and the achievement ratio was calculated and the results are shown in table 5.

TABLE 5

Achievement ratio (%)	Day 28	Day 56	Day 84
				Control group	45	65	56
Example 1	97	100	100
				Example 2	94	98	100
Example 3	92	97	100
				Example 4	90	97.5	99
Example 5	89	97	99
				Example 6	87	95	98
Example 7	85	93	95
				Comparative example 1	70	85	87
Comparative example 2	72	83	81

As can be seen from Table 5, the example group using the technical scheme of the present invention achieves the goal of less than 7% of glycated hemoglobin, both in rate and population ratio, significantly better than the control group and the comparative group; and the rate of increase of the target achievement ratio of the example group was significantly higher than that of the control group and the comparative group with the increase of the intake time. The main reason is that the low-carbon water diet only reduces the sugar metabolism stress load of the organism, but the product of the invention is more effective in solving the insulin resistance, recovering intestinal bacteria and islet energy supply, so that the organism can independently regulate the blood sugar level, and the product of the invention belongs to the extremely low GI food and well solves the sugar load problem of the organism.

It can be seen from the combination of tables 4 and 5 that low-carbon water diet can effectively reduce the mean blood sugar level and the glycated hemoglobin within 3 months (84 days), and the mean blood sugar level and the glycated hemoglobin are reduced by about 1%, but gradually rebounds to the standard of group after 6 months. The product of the invention can achieve 1.45 percent of average down regulation within eight weeks (56 days), and can not rebound continuously, and the glycosylated hemoglobin is maintained within a normal physiological range under the condition of islet energy supply recovery.

(4) Improvement of fasting blood glucose

Fasting blood glucose was measured by volunteers at day 0, day 28, day 56 and day 84 of participation in the test in the hospital trimester, and the declining ratios of day 28, day 56 and day 84 with respect to day 0 were calculated (declining ratio ═ th sky abdominal blood glucose value-nth sky abdominal blood glucose value)/(0 sky abdominal blood glucose value × 100%), and the average values of the experimental group and the control group were calculated, respectively, and the results are shown in table 6.

TABLE 6

Reduction ratio (%)	Day 28	Day 56	Day 84
				Control group	9.5	19.5	22.3
Example 1	37.5	39.3	41.2
				Example 2	37.2	40.1	39.3
Example 3	36.8	38.3	38.5
				Example 4	37.4	38.4	38.2
Example 5	35.8	38.2	37.5
				Example 6	35.1	38.8	37.2
Example 7	35.5	36.8	36.5
				Comparative example 1	25.5	32.6	33.5
Comparative example 2	25.1	35.7	32.3

As can be seen from table 6, for the improvement of fasting plasma glucose, the fasting plasma glucose level of the example group using the technical solution of the present invention decreased steadily and significantly within 3 months, and the example group was able to effectively lower and stabilize fasting plasma glucose of patients compared to the control group and the comparative group. Patients meeting the group entry condition can stabilize the fasting blood sugar within the clinical normal range within 8 weeks, and do not inject insulin or take oral medicines.

(5) Influence on intestinal cell secretion

The contents of G L P-1 and G L P-2 in the intestines were measured by volunteers at day 0, day 28, day 56 and day 84 participating in the test in Hospital, respectively, and the growth rates (%) on day 28, day 56 and day 84 with respect to day 0 were calculated, and the average values of the experimental group and the control group were calculated, respectively, as shown in Table 7.

G L P-1 is intestinal L type cell secretion and is glucose-dependent insulinotropic polypeptide, 60% of insulin secretion in human physiological state depends on G L P-1 to participate in secretion, G L P-1 also has the functions of nourishing pancreatic B cells and maintaining the stability and proliferation of the pancreatic B cells, and G L P-2 is intestinal cell secretion and mainly plays a role in repairing the structural function of intestinal wall cells and promoting the repair and proliferation of the intestinal wall cells.

TABLE 7

As can be seen from Table 7, compared with the control group and the comparative group, the experimental group adopting the technical scheme of the invention can more obviously improve the content of G L P-1 and G L P-2 in the intestinal tract, which shows that the product of the invention can effectively improve and nourish the intestinal wall L cells, thereby exciting the self pancreatic islet function from the internal source.

(6) Changes in the content of acetic acid and butyric acid in the intestinal tract

The contents of acetic acid and butyric acid in the stool samples were measured by volunteers at days 0, 28, 56 and 84 participating in the test, respectively, and the increase rates (%) on days 28, 56 and 84 with respect to day 0 were calculated and the average values of the experimental group and the control group were calculated, respectively, with the results shown in table 8.

It is noted that acetic acid and butyric acid are SCFA short chain fatty acids generated under the fermentation action of colonic bacteria, and can play a very significant regulating role in regulating energy supply and biological signals, thereby recovering the ecology and functions of intestinal flora, perfecting the structural function of colonic cell walls, arousing the function and proliferation of islet cells, regulating metabolic disorders, and recovering the regulating and balancing ability of the organism on metabolism. For example, acetic acid can regulate body antigens to promote the proliferation and the activity of T cells and inhibit the activity and the quantity of the T cells, butyric acid can regulate the immune attack of autoimmune T helper cells on islet B cells, and the regulation of the two can obviously reduce the immune damage of an autoimmune system on the islet B cells, so that the islet B cells are protected, and a safe and nutritional internal environment is provided for islet regeneration.

TABLE 8

As can be seen from table 8, compared to the control group and the comparative group, the example group using the technical scheme of the present invention can significantly increase the content of acetic acid and butyric acid, thereby effectively improving the pancreatic islet function.

In conclusion, the product of the invention can produce comprehensive regulation effect on the body, thereby effectively improving and even treating type II diabetes and being beneficial to improving the comprehensive quality of the body.

The preferred embodiments of the present invention have been described above in detail, but the present invention is not limited thereto. Within the scope of the technical idea of the invention, many simple modifications can be made to the technical solution of the invention, including combinations of various technical features in any other suitable way, and these simple modifications and combinations should also be regarded as the disclosure of the invention, and all fall within the scope of the invention.

Claims (10)

1. A nutritional dietary composition, which comprises flaxseed, chia seed, a component A and a component B, wherein the component A is soybean and/or red bean, and the component B is a mixture of total dietary fiber and total protein in a content weight ratio of 0.8-1: 1. a plant seed or a mixture of plant seeds having a total protein content of 8-25 wt% and a total carbon water content of 20-75 wt%;

wherein, relative to 100 weight parts of the flaxseed, the content of the chia seed is 40-70 weight parts, the content of the A component is 40-65 weight parts, and the content of the B component is 20-45 weight parts.

2. The composition according to claim 1, wherein the chia seed is present in an amount of 42-60 parts by weight, the a component is present in an amount of 42-60 parts by weight, and the B component is present in an amount of 22-40 parts by weight, relative to 100 parts by weight of the flaxseed.

3. The composition according to claim 2, wherein the chia seed is present in an amount of 45-55 parts by weight, the a component is present in an amount of 45-55 parts by weight, and the B component is present in an amount of 25-35 parts by weight, relative to 100 parts by weight of the flaxseed.

4. The composition of any one of claims 1-3, wherein the A component is soybean.

5. The composition according to any one of claims 1 to 3, wherein the content of the B component is 0.85 to 0.98 by weight of total dietary fiber to total protein: 1. a plant seed or a mixture of plant seeds having a total protein content of 12-20 wt% and a total carbon water content of 45-75 wt%.

6. The composition of claim 5, wherein the weight ratio of total dietary fiber to total protein in the B component is 0.85-0.98: 1. a plant seed or a mixture of plant seeds having a total protein content of 16-20 wt% and a total carbon water content of 50-65 wt%.

7. The composition of claim 6, wherein the B component is selected from one or more of pumpkin seeds, black beans, chickpeas and whole wheat.

8. The composition of claim 1 wherein the nutritional dietary composition is a powder having a particle size of 100 and 140 mesh.

9. An edible product comprising the nutritional dietary composition of any one of claims 1 to 8.

10. The edible product of claim 9, wherein the edible product is a food for regulating blood glucose, a food for weight loss, or a food for improving body constitution.